How the biological clock ticks in the female reproductive tract
Breakthrough of the Year Award 2025 for Ângela Gonçalves
Advertisement
Endometriosis, menopause, ovarian cancer – still poorly researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical findings to develop non-invasive tools for early detection, personalized care, and healthier aging – directly challenging gender bias in medicine. The scientist from the DKFZ-Hector Cancer Institute at the University Medical Center Mannheim is the winner of the Falling Walls Foundation's “Breakthrough of the Year 2025” award in the Women's Impact category.
Each menstrual cycle, the organs of female reproductive tract organs undergo tremendous buildup and remodeling followed by breakdown and repair. For a long time, it was assumed that these events left no traces or scars in the affected organs. Ângela Gonçalves' research has revealed the unexpected price of female reproductive capacity that results from the constant remodeling of the female reproductive tract. She has also been exploring pioneering solutions for non-invasive diagnosis by using menstrual blood. For this, the Falling Walls Foundation is honoring her with the Breakthrough of the Year award in the Women's Impact category.
Ângela Gonçalves studied computer science at the University of Coimbra in Portugal. After a research stay at the European Space Agency, she received a scholarship for a PhD in computational molecular biology at the European Bioinformatics Institute (EMBL EBI) and received her PhD from the University of Cambridge in 2012. She then conducted postdoctoral research in population genomics at the Wellcome Trust Sanger Institute.
Since 2018, Gonçalves has headed the Division of Computational and Molecular Prevention at the German Cancer Research Center (DKFZ). Since 2022, she has also been co-head of the Digital Cancer Prevention group at the National Cancer Prevention Center, and since 2024, she has been a full professor at Heidelberg University.
In 2025, the Hector Foundation II generously increased its funding for the DKFZ-Hector Cancer Institute at the University Medical Center Mannheim. This enabled the establishment of research areas such as prevention, early detection, and survivorship. As part of this expansion, Gonçalves was appointed to the DKFZ-Hector Cancer Institute. There, she investigates how mutated cell clones arise and spread before malignant tumors develop. To study these early stages, she combines experimental approaches with bioinformatic analyses and statistical modeling—with the long-term goal of improving cancer prevention.
Most read news
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Boehringer Ingelheim announces change in the company management - Harsha Deshmukh has been appointed as a member of the Executive Board with responsibility for IT and Global Business Services with effect from February 1, 2026
RNA Healer receives around one million euros for the development of a liver fibrosis therapy - MHH project wins start-up funding competition organised by Lower Saxony research incubator Institute for Biomedical Translation Lower Saxony.
New active ingredients for the treatment of heart failure - NRW-wide HI-FIVE research project launched
Smart sensor tag protects sensitive goods
Beverage industry relies on enzymatic PET recycling from CARBIOS - New purchase agreements bring French biotech company closer to production launch
Gempex and msg industry advisors cooperate in the field of AI-supported services in the GMP-regulated environment - Quality assurance more efficient, targeted and secure
Tacalyx appoints Jean Engela as Chief Executive Officer for the next phase of growth
NextPharma sells its logistics division to Cencora - The sale is part of the plan to position NextPharma as Europe's leading pure-play CDMO.
How an Invisible “Cap” could control Electrical Synapses - New Building Blocks of Cell Communication
A new tunable cell-sorting device with potential biomedical applications - Precise, label-free sorting of cells of various sizes possible due to a temperature-sensitive PNIPAM hydrogel array
Proteins in a crowd: European XFEL looks inside cells - Researchers observe in detail how the vital iron protein ferritin makes its way in highly dense environments